Posted 1 month ago UNMC researchers reach milestone in effort to slow or halt progression of Parkin ... While the drug is sometimes used in patients receiving chemotherapy, it has not been used previously in Parkinson’s.
Posted 2 months ago New Modalities for Challenging Targets in Drug Discovery An ever increasing understanding of biological systems is providing a range of exciting novel biological targets whose modulation may enable novel therapeutic options in many diseases. These targets include...
Posted 3 months ago Longevity Biotech and University of Nebraska Medical Center Awarded Continuing G ... Furthers development of LBT-3627 focusing on immunomodulatory therapeutic strategy to treat Parkinson's disease
Posted 8 months ago Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intest ... Neuroprotective immunity is defined by transformation of T-cell polarity for therapeutic gain. For neurodegenerative disorders and specifically for Parkinson’s disease (PD), granulocyte-macrophage col